About Dr. Milind M. Javle
Dr. Milind M. Javle, MD, is a medical oncologist specializing in cancers of the gastrointestinal system. At MD Anderson Cancer Center in Houston, he serves as Clinical Medical Director of Gastrointestinal Medical Oncology and Professor of Gastrointestinal Medical Oncology. His clinical and research work has a strong focus on hepatobiliary cancers, including bile duct cancer and cholangiocarcinoma.
His work also includes pancreatic and other gastrointestinal cancers, precision cancer treatment, targeted therapies, and clinical trials. Dr. Javle has held leadership roles in national and international groups studying hepatobiliary cancers and continues to participate in research evaluating new treatments for advanced biliary tract disease.
Patients looking for physicians providing similar cancer care can browse the Doctiplus oncology specialist directory.
Focus Areas
- Cholangiocarcinoma and bile duct cancer
- Gallbladder cancer
- Hepatobiliary cancers
- Pancreatic cancer
- Gastrointestinal medical oncology
- Advanced and metastatic gastrointestinal cancers
- Targeted cancer therapies
- Molecularly guided treatment
- Immunotherapy
- Oncology clinical trials
The National Cancer Institute provides patient information about bile duct cancer, including diagnosis and treatment considerations. Patients can also review the NCI guide to pancreatic cancer. For broader information about cancer treatment, the National Cancer Institute explains commonly used types of cancer treatment.
Gastrointestinal Oncology and Patient Care Approach
Gastrointestinal medical oncology focuses on cancers affecting organs involved in digestion, including the pancreas, liver, bile ducts, stomach, and intestines. Treatment may involve chemotherapy, immunotherapy, targeted therapy, molecular testing, or participation in a clinical trial, depending on the cancer type and stage.
Dr. Javle’s work is especially connected with precision treatment for biliary tract cancers. His current research includes studies of therapies designed for tumors with particular molecular changes, including FGFR alterations and other cancer-related mutations. This type of approach uses tumor characteristics to help determine which treatments may be appropriate for an individual patient.
Education and Credentials
Dr. Javle earned his medical degree from Grant Medical College, University of Bombay, in 1991. He completed an Internal Medicine internship and residency at the State University of New York at Buffalo between 1993 and 1995.
He then completed a Medical Oncology fellowship at Roswell Park Cancer Institute from 1995 to 1998. MD Anderson lists board certification in Internal Medicine in 1995 and Medical Oncology in 1997.
Clinic Information
Dr. Javle practices through the Department of Gastrointestinal Medical Oncology at The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030. His individual NPI is 1831196252.
Patients should confirm current appointment availability, referrals, insurance participation, and clinic location directly with MD Anderson before scheduling.
Cardiologist
Reviews
There are no reviews yet.